FTC Clears Barr’s Acquisition Of Pliva Based On Divestiture Of Generic Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Barr must divest three generic products – trazodone, triamterene/HCTZ and nimodipine – to Apotex and Banner.